查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701393

人體類器官市場規模、佔有率、趨勢分析報告：按產品、來源、器官類型、應用、最終用途、地區、細分市場預測，2025-2030 年

Human Organoids Market Size, Share & Trends Analysis Report By Product (Media & Supplements, Reagents, Organoid Models), By Sources, By Organ Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

人體類器官市場的成長與趨勢：

根據 Grand View Research, Inc. 的新報告，全球人類類器官市場規模預計到 2030 年將達到 27.2 億美元，2025 年至 2030 年的複合年成長率為 22.8%。

在幹細胞研究和 3D 細胞培養技術的進步推動下，市場正在經歷顯著成長。

市場的主要驅動力之一是對個人化醫療日益成長的需求。來自患者特異性幹細胞的類器官為研究個別疾病機制和測試客製化治療方法提供了獨特的平台。這種能力在腫瘤學中尤其有價值，因為腫瘤衍生的類器官可用於預測患者對化療和標靶治療的反應。隨著醫療保健轉向個人化治療策略，基於類器官的模型的採用預計將增加，進一步推動市場成長。

此外，癌症、神經退化性疾病和肝病等慢性疾病的盛行率不斷上升也是推動市場擴張的主要因素。類器官為研究這些病理提供了先進的模型，從而更深入地了解疾病機制並開發新的治療性介入。例如，腦類器官被用於研究阿茲海默症和帕金森氏症等神經系統疾病，而肝臟和腎臟類器官則有助於開發器官衰竭的治療方法。

儘管存在這些積極的趨勢，但諸如倫理問題、監管障礙以及與類器官開發相關的高成本等挑戰可能會帶來一些限制。然而，正在進行的研究努力和技術進步有望解決這些挑戰，並為類器官在生物醫學和臨床應用中的廣泛應用鋪平道路。

人體類器官市場報告重點

  • 根據產品，類器官模型部分在 2024 年佔據了市場主導地位。這一巨大佔有率歸因於藥物發現、疾病建模和再生醫學的日益普及。
  • 根據器官類型，肝臟部分將在 2024 年佔據市場主導地位。其在藥物代謝和毒性測試中的重要作用佔有很大佔有率。
  • 根據消息來源，成體幹細胞部分將在 2024 年引領人類類器官市場。
  • 根據應用，發育生物學在 2024 年主導了人類類器官市場。這一巨大佔有率是由於它們在理解細胞過程、組織工程和類器官發育方面發揮重要作用。
  • 根據最終用途，由於類器官技術在藥物發現、臨床前試驗和個人化醫療的應用日益廣泛，因此預計製藥和生物技術公司將在 2024 年佔據最大的市場佔有率。
  • 2024 年，北美將引領人類類器官市場。這是由於對生物技術、先進醫療保健基礎設施的大力投資，以及類器官技術在藥物發現和個人化醫療中的日益普及。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章 人體類器官市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 人類類器官市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章 人體類器官市場：依產品分類的預測與趨勢分析

  • 產品細分儀表板
  • 全球人體類器官市場（按產品）波動分析
  • 全球人類類器官市場規模及趨勢分析（依產品，2018-2030）
  • 媒體和補充資料
  • 試劑
  • 類器官模型

第5章 人體類器官市場：依供應來源估算及趨勢分析

  • 源細分儀表板
  • 全球人體類器官市場的波動
  • 全球人體類器官市場規模及趨勢分析（依來源）（2018-2030）
  • 成體幹細胞
  • 誘導多功能細胞
  • 胚胎幹細胞
  • 其他資訊來源

第6章 人體類器官市場：依器官類型分類的估價與趨勢

  • 器官類型細分儀表板
  • 全球人體類器官市場：器官類型變異分析
  • 全球人體類器官市場規模及趨勢分析（依器官類型，2018-2030）
  • 胃模型
  • 腸道模型
  • 肝臟模型
  • 胰臟模型
  • 肺模型
  • 大腦模型
  • 腎臟模型
  • 其他型號

第7章 人體類器官市場：依應用進行評估與趨勢分析

  • 應用程式細分儀表板
  • 全球人體類器官市場趨勢分析（依應用）
  • 全球人類類器官市場規模及趨勢分析（依應用，2018-2030）
  • 發育生物學
  • 藥物毒性和療效研究
  • 疾病的病理學
  • 個人化醫療
  • 再生醫學

第8章 人體類器官市場：依最終用途的估算與趨勢分析

  • 最終用途細分儀表板
  • 全球人體類器官市場依最終用途變化分析
  • 2018-2030年全球人體類器官市場規模及趨勢分析（依最終用途）
  • 製藥和生物技術公司
  • CRO 和 CMO
  • 學術研究所
  • 其他用途

第9章 人體類器官市場：按產品、器官類型、來源、應用和最終用途分類的區域估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018年至2030年市場規模與預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/列表
    • ATCC
    • Thermo Fisher Scientific Inc.
    • STEMCELL Technologies
    • Merck KGaA
    • Corning Incorporated
    • Bio-Techne.
    • ACROBiosystems.
    • .AMSBIO
    • Qkine Ltd.
    • PRIMACYT Cell Culture Technology GmbH
Product Code: GVR-4-68040-540-7

Human Organoids Market Growth & Trends:

The global human organoids market size is anticipated to reach USD 2.72 billion by 2030 and is projected to grow at a CAGR of 22.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth, driven by advancements in stem cell research and 3D cell culture technologies.

One of the key drivers of the market is the rising demand for personalized medicine. Organoids derived from patient-specific stem cells offer a unique platform for studying individual disease mechanisms and testing tailored treatment approaches. This capability is particularly valuable in oncology, where tumor-derived organoids can be used to predict patient responses to chemotherapy or targeted therapies. As healthcare shifts towards personalized treatment strategies, the adoption of organoid-based models is expected to increase, further fueling market growth.

Moreover, the growing prevalence of chronic diseases, such as cancer, neurodegenerative disorders, and liver diseases, is another major factor driving market expansion. Organoids provide an advanced model to study these conditions, leading to a deeper understanding of disease mechanisms and the development of novel therapeutic interventions. For instance, brain organoids are being used to study neurological conditions like Alzheimer's and Parkinson's disease, while liver and kidney organoids are helping researchers develop treatments for organ failure.

Despite these positive trends, challenges such as ethical concerns, regulatory hurdles, and high costs associated with organoid development may pose limitations to some extent. However, ongoing research efforts and technological advancements are expected to address these challenges, paving the way for the broader adoption of organoids in biomedical and clinical applications.

Human Organoids Market Report Highlights:

  • Based on product, the organoid models segment dominated the market in 2024. The large share is driven by increasing drug discovery, disease modeling, and regenerative medicine adoption.
  • Based on organ type, the liver segment dominated the market in 2024. The large share is driven by its critical role in drug metabolism and toxicity testing.
  • Based on source, the adult stem cells segment led the human organoids market in 2024, driven by their widespread use in disease modeling, drug discovery, and regenerative medicine.
  • Based on application, developmental biology dominated the human organoids market in 2024. The large share is driven by its critical role in understanding cellular processes, tissue engineering, and organoid development.
  • Based on end use, the pharmaceutical & biotechnology companies held the largest market share in 2024, driven by the increasing adoption of organoid technology in drug discovery, preclinical testing, and personalized medicine.
  • In 2024, North America led the human organoids market, driven by strong investments in biotechnology, advanced healthcare infrastructure, and increasing adoption of organoid technology in drug discovery and personalized medicine.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Organ Type
    • 1.2.3. Source
    • 1.2.4. Application
    • 1.2.5. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Human Organoids Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising research on gut-related diseases
      • 3.2.1.2. Advancements in microbiome studies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High development costs
  • 3.3. Human Organoids Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Human Organoids Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Human Organoids Market Product Movement Analysis
  • 4.3. Global Human Organoids Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Media & Supplements
    • 4.4.1. Media & supplements market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Reagents
    • 4.5.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Organoid Models
    • 4.6.1. Organoid Models market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Human Organoids Market: Source Estimates & Trend Analysis

  • 5.1. Source Segment Dashboard
  • 5.2. Global Human Organoids Market Source Movement Analysis
  • 5.3. Global Human Organoids Market Size & Trend Analysis, by Source, 2018 to 2030 (USD Million)
  • 5.4. Adult Stem Cells
    • 5.4.1. Adult stem cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Induced Pluripotent Stem Cells
    • 5.5.1. Induced pluripotent stem cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Embryonic Stem Cells
    • 5.6.1. Embryonic stem cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Other Sources
    • 5.7.1. Other sources market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Human Organoids Market: Organ Type Estimates & Trend Analysis

  • 6.1. Organ Type Segment Dashboard
  • 6.2. Global Human Organoids Market Organ Type Movement Analysis
  • 6.3. Global Human Organoids Market Size & Trend Analysis, by Organ Type, 2018 to 2030 (USD Million)
  • 6.4. Stomach Models
    • 6.4.1. Stomach models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Intestine Models
    • 6.5.1. Intestine models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Liver Models
    • 6.6.1. Liver models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Pancreatic Models
    • 6.7.1. Pancreatic models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Lung Models
    • 6.8.1. Lung models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Brain Models
    • 6.9.1. Brain models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.10. Kidney Models
    • 6.10.1. Kidney models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.11. Other Models
    • 6.11.1. Other models market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Human Organoids Market: Application Estimates & Trend Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. Global Human Organoids Market Application Movement Analysis
  • 7.3. Global Human Organoids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Developmental Biology
    • 7.4.1. Developmental biology market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Drug Toxicity & Efficacy Testing
    • 7.5.1. Drug toxicity & efficacy testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Disease Pathology
    • 7.6.1. Disease pathology market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Personalized Medicine
    • 7.7.1. Personalized medicine market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Regenerative Medicine
    • 7.8.1. Regenerative medicine market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Human Organoids Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Segment Dashboard
  • 8.2. Global Human Organoids Market End Use Movement Analysis
  • 8.3. Global Human Organoids Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Pharmaceutical & Biotechnology Companies
    • 8.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. CROs & CMOs
    • 8.5.1. CROs & CMOs market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Academic & Research Institutes
    • 8.6.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Other End Use
    • 8.7.1. Other end use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Human Organoids Market: Regional Estimates & Trend Analysis by Product, Organ Type, Source, Application, and End Use

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Regulatory framework
      • 9.5.7.3. Competitive scenario
      • 9.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Regulatory framework
      • 9.5.8.3. Competitive scenario
      • 9.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.9. Denmark
      • 9.5.9.1. Key country dynamics
      • 9.5.9.2. Regulatory framework
      • 9.5.9.3. Competitive scenario
      • 9.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. MEA
    • 9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework
      • 9.8.3.3. Competitive scenario
      • 9.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. Regulatory framework
      • 9.8.4.3. Competitive scenario
      • 9.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key country dynamics
      • 9.8.5.2. Regulatory framework
      • 9.8.5.3. Competitive scenario
      • 9.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. ATCC
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Thermo Fisher Scientific Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. STEMCELL Technologies
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Merck KGaA
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Corning Incorporated
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Bio-Techne.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. ACROBiosystems.
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. .AMSBIO
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Qkine Ltd.
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. PRIMACYT Cell Culture Technology GmbH
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global human organoids market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 5 Global human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 6 Global human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 8 North America human organoids market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 11 North America human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 12 North America human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 13 North America human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 14 U.S. human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 16 U.S. human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 17 U.S. human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 18 U.S. human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Canada human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 20 Canada human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 21 Canada human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 22 Canada human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 23 Canada human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Mexico human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 25 Mexico human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 26 Mexico human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 27 Mexico human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 28 Mexico human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Europe human organoids market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 31 Europe human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 32 Europe human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 33 Europe human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 34 Europe human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Germany human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 36 Germany human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 37 Germany human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 38 Germany human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 39 Germany human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 40 UK human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 41 UK human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 42 UK human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 43 UK human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 44 UK human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 45 France human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 46 France human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 47 France human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 48 France human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 49 France human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Italy human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 51 Italy human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 52 Italy human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 53 Italy human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 54 Italy human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Spain human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 56 Spain human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 57 Spain human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 58 Spain human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 59 Spain human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Denmark human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 61 Denmark human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 62 Denmark human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 63 Denmark human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 64 Denmark human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Sweden human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 66 Sweden human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 67 Sweden human organoids market, by sources, 2018 - 2030 (USD Million
  • Table 68 Sweden human organoids market, by application, 2018 - 2030 (USD Million
  • Table 69 Sweden human organoids market, by end use, 2018 - 2030 (USD Million
  • Table 70 Norway human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 71 Norway human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 72 Norway human organoids market, by sources, 2018 - 2030 (USD Million
  • Table 73 Norway human organoids market, by application, 2018 - 2030 (USD Million
  • Table 74 Norway human organoids market, by end use, 2018 - 2030 (USD Million
  • Table 75 Asia Pacific human organoids market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific human organoids market, by sources, 2018 - 2030 (USD Million
  • Table 78 Asia Pacific human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific human organoids market, by application, 2018 - 2030 (USD Million
  • Table 80 Asia Pacific human organoids market, by end use, 2018 - 2030 (USD Million
  • Table 81 China human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 82 China human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 83 China human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 84 China human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 85 China human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Japan human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 87 Japan human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 88 Japan human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 89 Japan human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 90 Japan human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 91 India human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 92 India human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 93 India human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 94 India human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 95 India human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 96 South Korea human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 97 South Korea human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 98 South Korea human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 99 South Korea human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 100 South Korea human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 101 Australia human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 102 Australia human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 103 Australia human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 104 Australia human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 105 Australia human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Thailand human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 107 Thailand human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 108 Thailand human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 109 Thailand human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 110 Thailand human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Latin America human organoids market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 113 Latin America human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 114 Latin America human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 115 Latin America human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 116 Latin America human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 117 Brazil human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 118 Brazil human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 119 Brazil human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 120 Brazil human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 121 Brazil human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 122 Argentina human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 123 Argentina human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 124 Argentina human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 125 Argentina human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 126 Argentina human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 127 MEA human organoids market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 129 MEA human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 130 MEA human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 131 MEA human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 132 MEA human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 133 South Africa human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 134 South Africa human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 135 South Africa human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 136 South Africa human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 137 South Africa human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 143 UAE human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 144 UAE human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 145 UAE human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 146 UAE human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 147 UAE human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 149 Kuwait human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 150 Kuwait human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 151 Kuwait human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 152 Kuwait human organoids market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Human organoids market: Market outlook
  • Fig. 5 Human organoids market: Segment outlook
  • Fig. 6 Human organoids market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Human organoids market driver impact
  • Fig. 9 Human organoids market restraint impact
  • Fig. 10 Human organoids market: Product outlook and key takeaways
  • Fig. 11 Human organoids market: Product movement analysis
  • Fig. 12 Media & supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Organoid Models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Human organoids market: Source outlook and key takeaways
  • Fig. 16 Human organoids market: Source movement analysis
  • Fig. 17 Adult stem cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Induced pluripotent stem cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Embryonic stem cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Other sources market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Human organoids market: Organ type outlook and key takeaways
  • Fig. 22 Human organoids market: Organ type movement analysis
  • Fig. 23 Stomach models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Intestine models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Liver models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Pancreatic models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Lung models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Brain models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Kidney models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Other models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Human organoids market: Application outlook and key takeaways
  • Fig. 32 Human organoids market: Application movement analysis
  • Fig. 33 Developmental biology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Drug toxicity & efficacy testing market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 35 Disease pathology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Personalized medicine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Regenerative medicine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Human organoids market: End use outlook and key takeaways
  • Fig. 39 Human organoids market: End use movement analysis
  • Fig. 40 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 CROs & CMOs market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 42 Academic & research institutes market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 43 Other end use market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 44 Global human organoids market: Regional outlook and key takeaways
  • Fig. 45 Global human organoids market: Regional movement analysis
  • Fig. 46 North America human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Canada human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Europe human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UK human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Germany human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 France human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Italy human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Spain human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Norway human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 China human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Japan human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 India human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Australia human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Middle East and Africa human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 UAE human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait human organoids market estimates and forecasts, 2018 - 2030 (USD Million)